Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS in a Syt1N13/Syt1AD4 background results in spontaneous neurotransmitter release frequency (measured as mEJPs) at third instar NMJs far beyond the levels observed in controls.
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS results in a dramatic increase in nerve-evoked excitatory junction potential (eEJP) amplitude without affecting asynchronous release or spontaneous fusion (as measured by mEJPs) at third instar NMJs at low (0.2mM) external Ca[2+], compared to controls.
There are no discernible synaptic abnormalities associated with over-expression of Syt1C2A*-C2B*.Scer\UAS, including no significant increase in the number of synaptic vesicles near active zones, compared to over-expression of Syt1C2A-C2B.Scer\UAS. There is also no significant change in the number of release sites between these two genotypes.
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS increases vesicle release probability and lowers the Ca[2+] concentration required to trigger fusion, compared to expression of Syt1C2A-C2B.Scer\UAS.
Scer\GAL4elav-C155/Syt1C2A*-C2B*.UAS partially rescues Syt1AD4/Syt1N13
Scer\GAL4elav-C155/Syt1C2A*-C2B*.UAS fails to rescue Syt1AD4/Syt1N13
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS fails to restore synchronous neurotransmitter release (measured as eEJPs) at third instar NMJs in Syt1N13/Syt1AD4 animals at either low (0.2mM) or high (1.0mM) external Ca[2+].
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS fails to restore spontaneous neurotransmitter release frequency (measured as mEJPs) to control levels at third instar NMJs in Syt1N13/Syt1AD4 animals at low (0.2mM) external Ca[2+]. Rather, mEJP frequency is dramatically increased.
Scer\GAL4elav-C155-mediated expression of Syt1C2A*-C2B*.Scer\UAS partially rescues the reduction in docked synaptic vesicles and vesicle density at type 1b boutons in Syt1N13/Syt1AD4 third instar larvae.